 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Healthwell Acquisition Corp. I (Healthwell) (Nasdaq: HWEL) announced today that (i) its previously announced special meeting of stockholders that was scheduled for December 4, 2023 has been...

Healthwell Acquisition Corp. I Announces Cancellation of Special Stockholder Meeting and its Intention to Liquidate

Healthwell Acquisition Corp. I (Healthwell) (Nasdaq: HWEL) announced today that its previously announced Business Combination Agreement in connection with its planned business combination with...

Healthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc.

Healthwell Acquisition Corp. I (Healthwell, HWEL or the Company) (NASDAQ: HWEL) announced today that it has postponed until further announcement the date of the special meeting of the Companys...

Healthwell Acquisition Corp. I Announces Postponement of the Special Meeting of Stockholders to Approve the Proposed Business Combination with Starton Therapeutics, Inc. and Related Transactions

Healthwell Acquisition Corp. I (Healthwell, HWEL or the Company) (NASDAQ: HWEL) announced today that it has postponed the date of the special meeting of the Companys stockholders (the Meeting) to...

Healthwell Acquisition Corp. I Announces New Meeting Date for the Special Meeting of Stockholders to Approve Proposed Business Combination With Starton Therapeutics, Inc. and Related Transactions

Starton Therapeutics Inc. (Starton or the Company), a clinical-stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, today entered into a definitive agreement to conduct its Phase 1b trial in multiple myeloma with a global...

Starton Therapeutics Contracts Global Clinical Research Organization to Conduct STAR-LLD Phase 1b Clinical Trial in Multiple Myeloma

Starton Therapeutics Inc. (Starton or the Company), a clinical stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, today provided updates on its Phase 1b STAR-LLD clinical trial of its investigational continuous delivery...

Starton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma

Starton Therapeutics, Inc. (Starton or the Company), a clinical-stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, and Healthwell Acquisition Corp. I (Nasdaq: HWEL) (Healthwell), a special purpose acquisition company...

Starton Therapeutics, Inc. and Healthwell Acquisition Corp. I to Present at the Jefferies Healthcare Conference

Healthwell Acquisition Corp. I operates as a blank check company. It focuses on technology-enabled companies across the entire healthcare industry. The company was founded on February 2, 2021 and is headquartered in Winnetka, IL.

Watchers	4
52-Wk Low	$9.14
52-Wk High	$11.88

Market Cap	$173.52M
Volume (M)	5.00
52-Wk High	$11.88
52-Wk Low	$9.14

HWEL Healthwell Acquisition Corp I - Ordinary Shares - Class A

About

Feed

News

Fundamentals